These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 25910414)
1. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers. Boakye CH; Patel K; Singh M Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414 [TBL] [Abstract][Full Text] [Related]
2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
3. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles. Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936 [TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier. Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464 [TBL] [Abstract][Full Text] [Related]
5. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Kim HK; Davaa E; Myung CS; Park JS Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines. Chen L; Alrbyawi H; Poudel I; Arnold RD; Babu RJ AAPS PharmSciTech; 2019 Feb; 20(3):99. PubMed ID: 30719596 [TBL] [Abstract][Full Text] [Related]
7. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213 [TBL] [Abstract][Full Text] [Related]
8. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids. Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641 [TBL] [Abstract][Full Text] [Related]
10. [Preparation and in vitro evaluation of pH-sensitive TAT peptide conjugated micelles]. Chen W; Jin MJ; Gao ZG; Wang LP; Piao HF Yao Xue Xue Bao; 2011 May; 46(5):599-604. PubMed ID: 21800551 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate. Shanmugam S; Song CK; Nagayya-Sriraman S; Baskaran R; Yong CS; Choi HG; Kim DD; Woo JS; Yoo BK Arch Pharm Res; 2009 Jul; 32(7):1067-75. PubMed ID: 19641889 [TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration. Kuai R; Yuan W; Li W; Qin Y; Tang J; Yuan M; Fu L; Ran R; Zhang Z; He Q Mol Pharm; 2011 Dec; 8(6):2151-61. PubMed ID: 21981683 [TBL] [Abstract][Full Text] [Related]
13. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating. Oumzil K; Khiati S; Grinstaff MW; Barthélémy P J Control Release; 2011 Apr; 151(2):123-30. PubMed ID: 21354443 [TBL] [Abstract][Full Text] [Related]
14. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245 [TBL] [Abstract][Full Text] [Related]
15. Size of thermosensitive liposomes influences content release. Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921 [TBL] [Abstract][Full Text] [Related]
16. Terpene-containing PEGylated liposomes as transdermal carriers of a hydrophilic compound. Rangsimawong W; Opanasopit P; Rojanarata T; Ngawhirunpat T Biol Pharm Bull; 2014; 37(12):1936-43. PubMed ID: 25297807 [TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288 [TBL] [Abstract][Full Text] [Related]
18. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells. Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854 [TBL] [Abstract][Full Text] [Related]
19. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. Li WM; Xue L; Mayer LD; Bally MB Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091 [TBL] [Abstract][Full Text] [Related]
20. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy. Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]